152 related articles for article (PubMed ID: 24117010)
1. (-)-Cytisine and derivatives: synthesis, reactivity, and applications.
Rouden J; Lasne MC; Blanchet J; Baudoux J
Chem Rev; 2014 Jan; 114(1):712-78. PubMed ID: 24117010
[No Abstract] [Full Text] [Related]
2. Core modification of cytisine: a modular synthesis.
Hirschhäuser C; Haseler CA; Gallagher T
Angew Chem Int Ed Engl; 2011 May; 50(22):5162-5. PubMed ID: 21520366
[No Abstract] [Full Text] [Related]
3. First total synthesis of (+/-)-3-hydroxy-11-norcytisine: structure confirmation and biological characterization.
Yohannes D; Hansen CP; Akireddy SR; Hauser TA; Kiser MN; Gurnon NJ; Day CS; Bhatti B; Caldwell WS
Org Lett; 2008 Dec; 10(23):5353-6. PubMed ID: 19007172
[TBL] [Abstract][Full Text] [Related]
4. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.
Pérez EG; Méndez-Gálvez C; Cassels BK
Nat Prod Rep; 2012 May; 29(5):555-67. PubMed ID: 22367109
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
[TBL] [Abstract][Full Text] [Related]
6. Syntheses of (+)-cytisine, (-)-kuraramine, (-)-isokuraramine, and (-)-jussiaeiine A.
Honda T; Takahashi R; Namiki H
J Org Chem; 2005 Jan; 70(2):499-504. PubMed ID: 15651792
[TBL] [Abstract][Full Text] [Related]
7. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
Coe JW; Vetelino MG; Bashore CG; Wirtz MC; Brooks PR; Arnold EP; Lebel LA; Fox CB; Sands SB; Davis TI; Schulz DW; Rollema H; Tingley FD; O'Neill BT
Bioorg Med Chem Lett; 2005 Jun; 15(12):2974-9. PubMed ID: 15908213
[TBL] [Abstract][Full Text] [Related]
8. Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.
Yohannes D; Procko K; Lebel LA; Fox CB; O'Neill BT
Bioorg Med Chem Lett; 2008 Apr; 18(7):2316-9. PubMed ID: 18356044
[TBL] [Abstract][Full Text] [Related]
9. A short synthesis of (+/-)-cytisine.
Botuha C; Galley CM; Gallagher T
Org Biomol Chem; 2004 Jul; 2(13):1825-6. PubMed ID: 15227532
[TBL] [Abstract][Full Text] [Related]
10. A flexible strategy for the synthesis of tri- and tetracyclic lupin alkaloids: synthesis of (+)-cytisine, (+/-)-anagyrine, and (+/-)-thermopsine.
Gray D; Gallagher T
Angew Chem Int Ed Engl; 2006 Apr; 45(15):2419-23. PubMed ID: 16521145
[No Abstract] [Full Text] [Related]
11. Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
Chellappan SK; Xiao Y; Tueckmantel W; Kellar KJ; Kozikowski AP
J Med Chem; 2006 May; 49(9):2673-6. PubMed ID: 16640326
[TBL] [Abstract][Full Text] [Related]
12. Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
Fitch RW; Kaneko Y; Klaperski P; Daly JW; Seitz G; Gündisch D
Bioorg Med Chem Lett; 2005 Feb; 15(4):1221-4. PubMed ID: 15686946
[TBL] [Abstract][Full Text] [Related]
13. Aza-Michael reaction of 12-N-carboxamide of (-)-cytisine under high pressure conditions.
Tsypysheva IP; Lobov AN; Kovalskaya AV; Petrova PR; Ivanov SP; Rameev SA; Borisevich SS; Safiullin RL; Yunusov MS
Nat Prod Res; 2015; 29(2):141-8. PubMed ID: 25330752
[TBL] [Abstract][Full Text] [Related]
14. Advances on the Bioactivities, Total Synthesis, Structural Modification, and Structure-Activity Relationships of Cytisine Derivatives.
Huang X; Xu H
Mini Rev Med Chem; 2020; 20(5):369-395. PubMed ID: 31686638
[TBL] [Abstract][Full Text] [Related]
15. Chemical medicine: novel 10-substituted cytisine derivatives with increased selectivity for alpha4beta2 nicotinic acetylcholine receptors.
Kozikowski AP; Chellappan SK; Xiao Y; Bajjuri KM; Yuan H; Kellar KJ; Petukhov PA
ChemMedChem; 2007 Aug; 2(8):1157-61. PubMed ID: 17530728
[No Abstract] [Full Text] [Related]
16. Identification of 9-fluoro substituted (-)-cytisine derivatives as ligands with high affinity for nicotinic receptors.
Houllier N; Gopisetti J; Lestage P; Lasne MC; Rouden J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6667-70. PubMed ID: 20880707
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of analogues of (-)-cytisine for in vivo studies of nicotinic receptors using positron emission tomography.
Marrière E; Rouden J; Tadino V; Lasne MC
Org Lett; 2000 Apr; 2(8):1121-4. PubMed ID: 10804569
[TBL] [Abstract][Full Text] [Related]
18. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
[TBL] [Abstract][Full Text] [Related]
19. Concise synthesis of (+/-)-cytisine via lithiation of N-Boc-bispidine.
Stead D; O'Brien P; Sanderson AJ
Org Lett; 2005 Sep; 7(20):4459-62. PubMed ID: 16178558
[TBL] [Abstract][Full Text] [Related]
20. [Crystal and molecular structure of cytisine salts].
Niedźwiecka J; Przybył AK; Kubicki M
Przegl Lek; 2012; 69(10):998-1003. PubMed ID: 23421078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
